---
title: "Sage Therap (SAGE.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/SAGE.US.md"
symbol: "SAGE.US"
name: "Sage Therap"
industry: "生物技術"
---

# Sage Therap (SAGE.US)

| Item | Detail |
|------|--------|
| Industry | 生物技術 |

## Company Profile

Sage Therapeutics, Inc.是一家生物制藥公司，專注于開發和商業化腦健康藥物。該公司提供 ZURZUVAE，這是一種神經活性類固醇，作為 GABA 受體的正向變構調節劑，針對突觸和突觸外 GABA 受體，用于治療成人產后抑鬱症。其產品管線還包括 SAGE-324，這是一種新型 GABA 受體正向變構調節劑，適用于慢性口服給藥，包括治療發育性和癲癇性腦病中的癲癇發作；以及 SAGE-319，一種偏好突觸外 GABA 受體的正向變構調節劑，用于治療與神經發育障礙相關的行為症狀。此外，該公司還在開發多種產品候選藥物，包括 SAGE-817 和 SAGE-039，用于治療急性和慢性腦...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.80 | 283/604 | - | - | - |
| PB | 1.47 | 178/604 | 1.47 | 1.47 | 1.03 |
| PS (TTM) | 7.72 | 171/604 | 11.36 | 7.72 | 7.72 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 8.68 |

## References

- [Company Overview](https://longbridge.com/en/quote/SAGE.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/SAGE.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/SAGE.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
